��躰�肽𨯙嚙踝蕭�椬��㮖����𠺪蕭��辷蕭
��躰�頣蕭皛抵�䈑蕭嚙踝蕭膌见�躰�肽𨯙
��躰�肽𨯙嚙踝蕭颲瑁𨯙�𢥫嚙質�嚙踢�𧶏蕭薳��𨯙
��躰釭嚙賢��𨯙嚙賡ㄤ��躰釭嚙賭�對蕭嚙�
��躰釭嚙賢��𨯙嚙踝蕭蒺矋蕭嚙賣���辷蕭
��躰�頣蕭嚙質𨯙��鞱�矋蕭��躰�肽𨯙嚙踢岡芾働嚙�
��躰�頣蕭皛抵�䈑蕭嚙踝蕭嚙賢�磰𨯙嚙踢﹜���躰�肽𨯙��躰�肽𨯙
嚙賭麩��躰�肽𨯙嚙賭�𡑒𨯙��躰�肽𨯙��躰�肽𨯙
��躰腺鈭�䁥滩𨯙嚙賡�嚙踝蕭��躰�頣蕭�迚�𨯙
��躰�肽𨯙嚙踝蕭嚙踢�佅嚙賢�躰�肽𨯙嚙踝蕭�迚�𨯙
��躰�肽𨯙嚙賜�嚙踝蕭臐�鳴蕭�莎蕭撠𩤃蕭臐�航𨯙��躰郭嚙踢岸��𨯙��辷蕭
��躰�肽𨯙��躰�肽𨯙嚙賡做嚙踢╱ｇ蕭暻芸�躰腺�𧊋臐�航𨯙��躰�肽𨯙
嚙踝蕭��嚙質�磰𨯙��躰�肽𨯙嚙賢䐓��躰釭臐�嚙踝蕭嚙踝蕭��辷蕭
��躰釭嚙賢��𨯙嚙踢�鍦�躰�栶�笔�辷蕭
��躰都嚙賢�躰腺嚙賬���躰腺嚙賢��
��躰酗��𥕦�躰郭��嚙賢��𨯙��鮋ㄙ
��躰都嚙賢�躰腺嚙賬���躰�肽𨯙��躰�肽𨯙��辷蕭
��躰都嚙賢�躰腺嚙賬�嚙踝蕭嚙質𨯙��躰�肽𨯙
��躰酗藆�坿���嚙質�𨅯�𡑒��𨯙��辷蕭
��躰酗��𨥈蕭嚙踢�航𨯙嚙踝蕭嚙踝蕭臐��𨯙
嚙踢坎萘���朞𨯙�坾蝞�嚙賢�躰�肽𨯙��辷蕭
��躰閉瘣賢�躰酗嚙踢�航𨯙�����𨯙��辷蕭
嚙踢△�嚙踝蕭嚙質𨯙嚙踝蕭璇寡𨯙��辷蕭
��躰�肽𨯙��躰腺銝滚��𨯙��躰�肽𨯙��躰�肽𨯙
��躰�肽𨯙��𥕦�页蕭���𧒆䕘蕭薴ㄟ��躰腺��舘�舘𨯙
��躰腺鈭�䁥滩𨯙嚙賡�嚙踢�𦴣��躰�肽𨯙��躰�肽𨯙
��躰閉�蕟��躰�肽𨯙��嚙踝蕭�𨯙��琜蕭藃�讛𨯙��辷蕭
嚙踝蕭薳閦�𥕦�𩤃蕭嚙質𨯙��躰�肽𨯙��躰�肽𨯙
嚙踝蕭薳閦�𥕦�𩤃蕭嚙質𨯙��躰部薴钟��辷蕭
��躰腺嚙賣�坿𨯙��嚙賣Ⅰ�𨯙��躰�肽𨯙��辷蕭
��躰腺嚙賣�坿𨯙��嚙賜�橘蕭嚙質�芷礆嚙�
嚙踝蕭臐号艟洽嚙踝蕭��磰𨯙��躰�肽𨯙��辷蕭
��躰�肽𨯙嚙賢𠘕嚙賢𠹭��㚁蕭銧游�辷蕭
��躰�肽𨯙��𥟇䠋�𨯙��躰�肽𨯙��𥪮�航𨯙
嚙踝蕭�緾嚙賢�躰郭嚙賭�𡑒𨯙嚙踝蕭嚙�
��躰�肽𨯙嚙踢╱Ｚ躀臐��𨯙��躰�肽𨯙��辷蕭
嚙踝蕭艟妟��𥕦�躰郭嚙賭�𤏸𨯙��躰�肽𨯙��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭嚙踝蕭�佞𧒆��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭擗�𠯫�𧒆��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭憍辷蕭�莎蕭嚙質鷄嚙踝蕭
��躰�肽𨯙��𥕦��𨯙嚙賜�皜脩腦嚙踢𧒆��辷蕭
��躰�肽𨯙��𥕦��𨯙嚙賜�皜賂蕭�樹𧒆��辷蕭
嚙踝蕭艟妟��𥕦�躰釭�𡁜�躰腺嚙踝蕭藂��𨯙��躰釭蝮�蕭�𧒆��辷蕭
嚙踝蕭艟妟��𥕦�躰釭�𡁜�躰腺嚙踝蕭藂��𨯙��躰郭嚙賜�樹𧒆��辷蕭
��躰腺�亙�滩𨯙��躰�頣蕭��𡏭𨯙��躰�肽𨯙�����痹蕭嚙�
��躰�肽𨯙嚙踢𧒆䕘蕭嚙踢孜讛𨯙��躰�肽𨯙��辷蕭
嚙踝蕭���蕭�䁥滩𨯙��琜蕭�迚�𨯙��辷蕭
��躰�肽𨯙��躰郭�𨺗��躰�肽𨯙
��躰�肽𨯙��躰�肽𨯙嚙踝蕭隤抵���嚙賬答�𨯙��躰�肽𨯙
新巨(2420)
月營收
季盈餘
2025/03/01
58.70元 (新巨股價)
2025/03/01
-7.92%
(年增率)
197百萬元 (營收)
新巨(2420) 年度營收走勢圖
12
192百萬/月 (110年)
182百萬/月 (111年)
147百萬/月 (112年)
176百萬/月 (113年)
N/A百萬/月 (114年)
新巨(2420)月營收明細
單位：仟元
年/月
營收
月增率
去年同期
年增率
累計營收
年增率
114/03
196,983
13.78%
213,929
-7.92%
543,680
-2.18%
114/02
173,127
-0.25%
139,210
24.36%
346,697
1.41%
114/01
173,569
-1.77%
202,661
-14.36%
173,569
-14.36%
113/12
176,699
-0.90%
147,295
19.96%
2,237,868
5.32%
113/11
178,306
-1.57%
169,849
4.98%
2,061,170
4.23%
113/10
181,158
8.27%
184,981
-2.07%
1,882,864
4.16%
113/09
167,314
-20.31%
180,732
-7.42%
1,701,706
4.87%
113/08
209,957
2.39%
168,927
24.29%
1,534,392
6.41%
113/07
205,050
7.83%
180,881
13.36%
1,324,434
4.04%
113/06
190,157
-3.89%
176,062
8.01%
1,119,384
2.49%
113/05
197,847
12.68%
182,188
8.59%
929,227
1.44%
113/04
175,580
-17.93%
179,406
-2.13%
731,380
-0.34%
113/03
213,929
53.67%
212,491
0.68%
555,801
0.24%
113/02
139,210
-31.31%
152,503
-8.72%
341,871
-0.04%
113/01
202,661
37.59%
189,492
6.95%
202,661
6.95%
112/12
147,295
-13.28%
182,719
-19.39%
2,124,808
-19.51%
112/11
169,849
-8.18%
210,246
-19.21%
1,977,512
-19.52%
112/10
184,981
2.35%
190,455
-2.87%
1,807,664
-19.55%
112/09
180,732
6.99%
233,690
-22.66%
1,622,683
-21.09%
112/08
168,927
-6.61%
223,732
-24.50%
1,441,951
-20.89%
112/07
180,881
2.74%
231,808
-21.97%
1,273,023
-20.39%
112/06
176,062
-3.36%
226,668
-22.33%
1,092,142
-20.12%
112/05
182,188
1.55%
256,181
-28.88%
916,080
-19.68%
112/04
179,406
-15.57%
251,403
-28.64%
733,892
-17.02%
112/03
212,491
39.34%
247,531
-14.16%
554,485
-12.40%
112/02
152,503
-19.52%
162,850
-6.35%
341,994
-11.27%
112/01
189,492
3.71%
222,597
-14.87%
189,492
-14.87%
111/12
182,719
-13.09%
192,023
-4.85%
2,639,881
-0.62%
111/11
210,246
10.39%
235,273
-10.64%
2,457,162
-0.29%
111/10
190,455
-18.50%
218,981
-13.03%
2,246,915
0.81%
111/09
233,690
4.45%
238,487
-2.01%
2,056,461
2.31%
111/08
223,732
-3.48%
237,241
-5.69%
1,822,770
2.90%
111/07
231,808
2.27%
236,843
-2.13%
1,599,038
4.22%
111/06
226,668
-11.52%
227,923
-0.55%
1,367,230
5.38%
111/05
256,181
1.90%
252,130
1.61%
1,140,562
6.65%
111/04
251,403
1.56%
247,947
1.39%
884,381
8.20%
111/03
247,531
52.00%
190,555
29.90%
632,978
11.17%
111/02
162,850
-26.84%
385,447
111/01
222,597
15.92%
222,597
110/12
192,023
-18.38%
2,656,248
110/11
235,273
7.44%
2,464,225
110/10
218,981
-8.18%
2,228,952
110/09
238,487
0.53%
2,009,971
110/08
237,241
0.17%
1,771,484
110/07
236,843
3.91%
1,534,243
110/06
227,923
-9.60%
1,297,400
110/05
252,130
1.69%
1,069,477
110/04
247,947
30.12%
817,347
說明：自2013年起上市櫃公司因IFRSs會計準則規範，每月公告的營收必須是合併營收，不再公告非合併營收。2012年(含)前，合併營收是採自願公告。
